Company Filing History:
5 out of 138 
3 out of 330 
1 out of 1 Years Active: 2014-2025
Title: Xuechen Li: Innovator in Antibacterial Cyclic Lipopeptides
Introduction
Xuechen Li, based in Hong Kong, CN, is an accomplished inventor with a notable portfolio comprising 10 patents. His work primarily focuses on antibacterial compounds and their applications in treating microbial infections, contributing significantly to the field of pharmaceutical sciences.
Latest Patents
Li's recent patents include groundbreaking innovations such as "Antibacterial Cyclic Lipopeptides." This patent describes cyclic lipopeptides that have undergone modifications relative to daptomycin, offering new methods of synthesis that allow for the introduction of unnatural amino acids and enhancements tailored to create effective antibacterial agents. Another significant patent titled "Compounds and Methods for the Treatment of Microbial Infections" provides innovative compounds and their derivatives, focusing on methods for preventing and treating various microbial infections, particularly bacterial infections like staphylococcal infections.
Career Highlights
Xuechen Li has made his mark in the industry through his work in reputable organizations such as Versitech, Inc. and The University of Hong Kong. His contributions to these institutions have advanced research in antimicrobial therapies, showcasing his commitment to combatting bacterial infections through innovation.
Collaborations
Throughout his career, Li has had the opportunity to collaborate with other notable professionals, including Yi Tsun Richard Kao and Peng Gao. These partnerships have fostered an environment of innovation, aiding in the development of his significant research efforts and patent applications.
Conclusion
Xuechen Li continues to be an influential figure in the realm of antibacterial research. His extensive patent portfolio reflects a dedication to creating effective solutions for microbial infections, positioning him as a key innovator in the pharmaceutical field. As research evolves, Li's contributions promise to make a lasting impact on public health and safety.